Emerging Focus on Perimenopause Care
According to a report by Wired on September 1, 2026, a coalition of tech startups, MAHA (Make America Healthy Again) movement operatives, and medical professionals is positioning millennial women as a new primary demographic for hormone therapy during perimenopause.
Convergence of Healthtech and Medical Policy
Wired highlights that the convergence of healthtech platforms, health policy activists, and traditional medical expertise has created an integrated service ecosystem. This initiative directly addresses the healthcare needs of younger women compared to the traditional demographic historically associated with hormone replacement therapies.